Associate Professor, Medicine, University of Alabama School of Medicine
Internal Medicine
Dr. Mark T. Dransfield, MD
Mark T. Dransfield, MD practices Internal Medicine. He graduated from University of Alabama Medical Center. University of Alabama Medical Center is ranked 37 in research and 17 in primary care medicine He received awards:"Regional Top Doctor" and "Meaningful Use Stage 1 Certification". Dr. Mark T. Dransfield is a published doctor as well. He has 37 publications published. The latest was: Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort. Doctor Mark T. Dransfield, MD accepts Medicare.
Publications
- Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus Clearance.
- Association Between Expiratory Central Airway Collapse and Respiratory Outcomes Among Smokers.
- Sex-specific features of emphysema among current and former smokers with COPD.
- β-Blockers are associated with a reduction in COPD exacerbations.
- Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines.
- Pneumonia Risk with Inhaled Fluticasone Furoate and Vilanterol Compared with Vilanterol Alone in Patients with COPD.
- Subsets of airway myeloid-derived regulatory cells distinguish mild Asthma from chronic obstructive pulmonary disease.
- Cardiovascular disease in COPD: a call for action.
- The efficacy of restaging endobronchial ultrasound in patients with non-small cell Lung cancer after preoperative therapy.
- Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction: authors' response.
- Radiological correlates and clinical implications of the paradoxical Lung function response to β2 agonists: an observational study.
- Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients.
- Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD.
- Predictors of COPD Exacerbation Reduction in Response to Daily Azithromycin Therapy.
- Computed tomographic measures of airway morphology in smokers and never-smoking normals.
- FEV1/FEV6 to Diagnose Airflow Obstruction: Comparisons with Computed Tomography and Morbidity Indices.
- AECOPD: Acute Exacerbations of Chronic Obstructive Cardiopulmonary Disease?
- CFTR Activation by Roflumilast Contributes to Therapeutic Benefit in Chronic Bronchitis.
- Tumour necrosis factor receptor 75 and risk for COPD exacerbation in the azithromycin trial.
- Cigarette Smoke Induces Systemic Defects in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function.
- Chronic obstructive pulmonary disease and cardiovascular disease.
- Computed Tomographic Measures of Pulmonary Vascular Morphology in Smokers and their Clinical Implications.
- GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.
- Effect of Emphysema on CT scan measures of airway dimensions in smokers.
- Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.
- Pulmonary arterial enlargement and acute exacerbations of COPD.
- A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung Disease.
- Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in Chronic obstructive pulmonary disease.
- Biologic lung volume reduction in advanced upper lobe Emphysema: phase 2 results.
- Racial and sex differences in Chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment.
- Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort.
- Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.
- Impact of heterozygote CFTR mutations in COPD patients with chronic Bronchitis.
- Determinants of arterial stiffness in COPD.
- Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations.
- Pathophysiology and clinical implications of Pulmonary arterial enlargement in COPD.
Schools
University Of North Carolina Chapel Hill School Of Medicine
University Ala School Med
Procedures Preformed
- Bronchoscopy
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Alkalosis
- Asbestosis
- Asthma
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
- Internal Medicine
Accepted Insurances
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
Education
-
University of Alabama Medical Center -
University of North Carolina at Chapel Hill School of Medicine
Hospital
-
University of Alabama Hospital -
Birmingham Veterans Affairs Medical Center
Drug Facts
| NPI NUMBER | 1770526725 | |
| NPPES Provider LastName | DRANSFIELD | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 35233 | |
| NPPES Provider State | AL | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 483.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 21.0 | |
| Percent Opioid Claims | 4.35 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1770526725 |
| Last Name Of The Provider | DRANSFIELD |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
Dr. William B. Boyd, MD |
|
|
Dr. Wayne W. Killion Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carolyn E. Kezar, MD |
|
|
Dr. Lisa K. Wright, MD |
|
|
Dr. Ellouise M. Cotton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth G. Varley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald M. Roan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sandeep S. Virk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kirk B. Russ, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Niket Nathani, MD |
|
|
Uchenna G. Ifediba, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tiffany T. Mayo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Enrique D. Diaz Guzman Zavala, MD
This Doctor is OpenDoctor Recommended.
|